Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors von Khan, Nagma, Jeffers, Michael, Kumar, Sampath, Hackett, Craig, Boldog, Ferenc, Khramtsov, Nicholai, Qian, Xiaozhong, Mills, Evan, Berghs, Stanny C, Carey, Nessa, Finn, Paul W, Collins, Laura S, Tumber, Anthony, Ritchie, James W, Jensen, Peter Buhl, Lichenstein, Henri S, Sehested, Maxwell

Volltext

The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo von TUMBER, Anthony, COLLINS, Laura S, PETERSEN, Kamille Dumong, THOUGAARD, Annemette, CHRISTIANSEN, Sanne J, DEJLIGBJERG, Marielle, JENSEN, Peter Buhl, SEHESTED, Maxwell, RITCHIE, James W. A

Volltext

A drug response predictor to guide treatment for breast cancer von Buhl, Ida Kappel, Jensen, Peter Buhl, Kappel Buhl, Anna Sofie, Knudsen, Steen

Volltext

Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts von Buhl, Ida Kappel, Santoni-Rugiu, Eric, Ravn, Jesper, Hansen, Anker, Christensen, Ib Jarle, Jensen, Thomas, Pratt, Bruce, Askaa, Jon, Jensen, Peter Buhl, Knudsen, Steen, Sørensen, Jens Benn

Volltext

A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia von Gimsing, Peter, Hansen, Mads, Knudsen, Lene M., Knoblauch, P., Christensen, Ib Jarle, Ooi, Chean Eng, Buhl-Jensen, Peter

Volltext

A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors von STEELE, Nicola L, PLUMB, Jane A, DEBONO, Johann S, VIDAL, Laura, TJØRNELUND, Jette, KNOBLAUCH, Poul, RASMUSSEN, Annie, CHEAN ENG OOI, BUHL-JENSEN, Peter, BROWN, Robert, EVANS, T. R. Jeffry

Volltext

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded... von Buhl, Anna Sofie Kappel, Christensen, Troels Dreier, Christensen, Ib Jarle, Nelausen, Knud Mejer, Balslev, Eva, Knoop, Ann Søegaard, Brix, Eva Harder, Svensson, Else, Glavicic, Vesna, Luczak, Adam, Langkjer, Sven Tyge, Linnet, Søren, Jakobsen, Erik Hugger, Bogovic, Jurij, Ejlertsen, Bent, Rasmussen, Annie, Hansen, Anker, Knudsen, Steen, Nielsen, Dorte, Jensen, Peter Buhl

Volltext

Cell Line Derived 5-FU and Irinotecan Drug-Sensitivity Profiles Evaluated in Adjuvant Colon Cancer Trial Data von Buhl, Ida Kappel, Gerster, Sarah, Delorenzi, Mauro, Jensen, Thomas, Jensen, Peter Buhl, Bosman, Fred, Tejpar, Sabine, Roth, Arnaud, Brunner, Nils, Hansen, Anker, Knudsen, Steen

Volltext

Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer von Winther, Mette, Knudsen, Steen, Dahlgaard, Jesper, Jensen, Thomas, Hansen, Anker, Jensen, Peter Buhl, Tramm, Trine, Alsner, Jan, Nordsmark, Marianne

Volltext

Anticancer agent CHS-828 inhibits cellular synthesis of NAD von Olesen, Uffe Høgh, Christensen, Mette Knak, Björkling, Fredrik, Jäättelä, Marja, Jensen, Peter Buhl, Sehested, Maxwell, Nielsen, Søren Jensby

Volltext

Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer von Prahm, Kira Philipsen, Høgdall, Claus, Karlsen, Mona Aarenstrup, Christensen, Ib Jarle, Novotny, Guy Wayne, Knudsen, Steen, Hansen, Anker, Jensen, Peter Buhl, Jensen, Thomas, Mirza, Mansoor Raza, Ekmann-Gade, Anne Weng, Nedergaard, Lotte, Høgdall, Estrid

Volltext

Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay von Christensen, Troels Dreier, Buhl, Anna Sofie Kappel, Christensen, Ib Jarle, Buhl, Ida Kappel, Balslev, Eva, Knoop, Ann S., Danø, Hella, Glavicic, Vesna, Luczak, Adam, Langkjer, Sven Tyge, Linnet, Søren, Jakobsen, Erik Hugger, Bogovic, Jurij, Ejlertsen, Bent, Rasmussen, Annie, Hansen, Anker, Knudsen, Steen, Jensen, Peter Buhl, Nielsen, Dorte

Volltext

Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET von Munk Jensen, Mette, Erichsen, Kamille Dumong, Björkling, Fredrik, Madsen, Jacob, Jensen, Peter Buhl, Sehested, Maxwell, Højgaard, Liselotte, Kjær, Andreas

Volltext

[18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts von Jensen, Mette Munk, Erichsen, Kamille Dumong, Johnbeck, Camilla Bardram, Björkling, Fredrik, Madsen, Jacob, Bzorek, Michael, Jensen, Peter Buhl, Højgaard, Liselotte, Sehested, Maxwell, Kjær, Andreas

Volltext

Early detection of response to experimental chemotherapeutic Top216 with [18F]FLT and [18F]FDG PET in human ovary cancer xenografts in mice von Jensen, Mette Munk, Erichsen, Kamille Dumong, Björkling, Fredrik, Madsen, Jacob, Jensen, Peter Buhl, Højgaard, Liselotte, Sehested, Maxwell, Kjær, Andreas

Volltext

Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane von Langer, Seppo W., Thougaard, Annemette V., Sehested, Maxwell, Jensen, Peter Buhl

Volltext

[18F]FLT PET for non-invasive assessment of tumor sensitivity to chemotherapy: studies with experimental chemotherapy TP202377 in human cancer xenografts in mice von Munk Jensen, Mette, Erichsen, Kamille Dumong, Björkling, Fredrik, Madsen, Jacob, Jensen, Peter Buhl, Sehested, Maxwell, Højgaard, Liselotte, Kjær, Andreas

Volltext

Novel small molecule drugs inhibit tumor cell metabolism and show potent anti-tumorigenic potential von Trojel-Hansen, Christina, Erichsen, Kamille Dumong, Christensen, Mette Knak, Jensen, Peter Buhl, Sehested, Maxwell, Nielsen, Søren Jensby

Volltext

Dexrazoxane Protects against Myelosuppression from the DNA Cleavage–Enhancing Drugs Etoposide and Daunorubicin but not Doxorubicin von HOFLAND, Kenneth Francis, THOUGAARD, Annemette Vinding, SEHESTED, Maxwell, JENSEN, Peter Buhl

Volltext

Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone von LANGER, Seppo W, THOUGAARD, Annemette V, SEHESTED, Maxwell, JENSEN, Peter Buhl

Volltext